Edwards Lifesciences Return on Tangible Equity 2010-2023 | EW
Current and historical return on tangible equity values for Edwards Lifesciences (EW) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Edwards Lifesciences Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2023-12-31 | $1.40B | $5.04B | 29.44% |
| 2023-09-30 | $1.43B | $5.00B | 31.14% |
| 2023-06-30 | $1.39B | $4.72B | 30.59% |
| 2023-03-31 | $1.49B | $4.31B | 33.24% |
| 2022-12-31 | $1.52B | $4.36B | 33.89% |
| 2022-09-30 | $1.46B | $4.79B | 32.51% |
| 2022-06-30 | $1.46B | $4.46B | 33.83% |
| 2022-03-31 | $1.54B | $4.36B | 37.58% |
| 2021-12-31 | $1.50B | $4.34B | 39.60% |
| 2021-09-30 | $1.48B | $4.05B | 42.51% |
| 2021-06-30 | $1.46B | $3.64B | 46.56% |
| 2021-03-31 | $0.85B | $3.16B | 30.20% |
| 2020-12-31 | $0.82B | $3.07B | 31.34% |
| 2020-09-30 | $0.79B | $2.71B | 31.48% |
| 2020-06-30 | $0.74B | $2.34B | 30.81% |
| 2020-03-31 | $1.11B | $2.40B | 47.85% |
| 2019-12-31 | $1.05B | $2.64B | 47.24% |
| 2019-09-30 | $0.77B | $2.28B | 39.16% |
| 2019-06-30 | $0.73B | $1.94B | 39.19% |
| 2019-03-31 | $0.77B | $2.00B | 43.53% |
| 2018-12-31 | $0.72B | $1.69B | 43.45% |
| 2018-09-30 | $0.71B | $1.77B | 45.03% |
| 2018-06-30 | $0.66B | $1.58B | 41.52% |
| 2018-03-31 | $0.56B | $1.62B | 35.47% |
| 2017-12-31 | $0.58B | $1.36B | 38.29% |
| 2017-09-30 | $0.75B | $1.77B | 45.73% |
| 2017-06-30 | $0.72B | $1.57B | 43.37% |
| 2017-03-31 | $0.66B | $1.40B | 39.39% |
| 2016-12-31 | $0.57B | $1.79B | 33.82% |
| 2016-09-30 | $0.55B | $1.86B | 33.34% |
| 2016-06-30 | $0.53B | $1.63B | 33.27% |
| 2016-03-31 | $0.52B | $1.47B | 31.09% |
| 2015-12-31 | $0.50B | $1.67B | 28.34% |
| 2015-09-30 | $0.46B | $1.59B | 26.05% |
| 2015-06-30 | $0.44B | $1.90B | 24.60% |
| 2015-03-31 | $0.87B | $1.83B | 51.74% |
| 2014-12-31 | $0.81B | $1.79B | 55.40% |
| 2014-09-30 | $0.78B | $1.64B | 59.88% |
| 2014-06-30 | $0.76B | $1.50B | 66.84% |
| 2014-03-31 | $0.31B | $0.92B | 29.22% |
| 2013-12-31 | $0.39B | $1.13B | 35.39% |
| 2013-09-30 | $0.40B | $0.99B | 37.50% |
| 2013-06-30 | $0.40B | $1.13B | 35.63% |
| 2013-03-31 | $0.37B | $1.15B | 34.23% |
| 2012-12-31 | $0.29B | $1.03B | 28.03% |
| 2012-09-30 | $0.27B | $1.13B | 26.20% |
| 2012-06-30 | $0.25B | $1.02B | 25.74% |
| 2012-03-31 | $0.24B | $0.98B | 25.10% |
| 2011-12-31 | $0.24B | $0.92B | 25.28% |
| 2011-09-30 | $0.24B | $0.94B | 25.46% |
| 2011-06-30 | $0.24B | $0.96B | 25.63% |
| 2011-03-31 | $0.24B | $0.93B | 27.38% |
| 2010-12-31 | $0.22B | $0.93B | 26.92% |
| 2010-09-30 | $0.20B | $0.85B | 26.20% |
| 2010-06-30 | $0.23B | $0.73B | 31.22% |
| 2010-03-31 | $0.22B | $0.75B | 31.27% |
| 2009-12-31 | $0.23B | $0.76B | 35.94% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $52.819B | $6.005B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $219.329B | 26.67 |
| Intuitive Surgical (ISRG) | United States | $133.752B | 80.57 |
| DexCom (DXCM) | United States | $53.067B | 88.74 |
| IQVIA Holdings (IQV) | United States | $43.310B | 25.69 |
| IDEXX Laboratories (IDXX) | United States | $41.012B | 49.04 |
| Alcon (ALC) | Switzerland | $39.823B | 29.37 |
| STERIS (STE) | Ireland | $20.355B | 24.09 |
| Waters (WAT) | United States | $18.582B | 26.66 |
| Hologic (HOLX) | United States | $18.119B | 20.00 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.651B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.605B | 15.56 |
| ShockWave Medical (SWAV) | United States | $12.286B | 84.89 |
| Sysmex ADR (SSMXY) | Japan | $10.120B | 31.74 |
| Teleflex (TFX) | United States | $9.944B | 15.61 |
| Penumbra (PEN) | United States | $7.961B | 98.42 |
| Masimo (MASI) | United States | $7.246B | 40.64 |
| Globus Medical (GMED) | United States | $6.941B | 22.00 |
| Glaukos (GKOS) | United States | $5.074B | 0.00 |
| Integer Holdings (ITGR) | United States | $3.950B | 25.25 |
| LivaNova (LIVN) | United Kingdom | $2.969B | 19.58 |
| TransMedics (TMDX) | United States | $2.964B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.763B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.704B | 18.55 |
| Nihon Kohden (NHNKY) | Japan | $2.379B | 20.12 |
| Integra LifeSciences Holdings (IART) | United States | $2.309B | 9.48 |
| Tandem Diabetes Care (TNDM) | United States | $2.258B | 0.00 |
| Inari Medical (NARI) | United States | $2.151B | 371.10 |
| RxSight (RXST) | United States | $2.031B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.784B | 0.00 |
| Veracyte (VCYT) | United States | $1.489B | 0.00 |
| OPKO Health (OPK) | United States | $0.871B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.867B | 16.03 |
| Artivion (AORT) | United States | $0.856B | 98.95 |
| Paragon 28 (FNA) | United States | $0.833B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.729B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.692B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.671B | 0.00 |
| SiBone (SIBN) | United States | $0.627B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.575B | 19.53 |
| IRadimed (IRMD) | United States | $0.531B | 30.81 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.495B | 0.00 |
| Nevro (NVRO) | United States | $0.469B | 0.00 |
| NeuroPace (NPCE) | United States | $0.402B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.394B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.379B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.346B | 11.66 |
| CVRx (CVRX) | United States | $0.309B | 0.00 |
| AxoGen (AXGN) | United States | $0.305B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.279B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.263B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.242B | 0.00 |
| Accuray (ARAY) | United States | $0.220B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.190B | 10.26 |
| Atossa Genetics (ATOS) | United States | $0.187B | 0.00 |
| 908 Devices (MASS) | United States | $0.183B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.174B | 0.00 |
| Inogen (INGN) | United States | $0.162B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.149B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.142B | 0.00 |
| Neuronetics (STIM) | United States | $0.116B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.112B | 0.00 |
| Envoy Medical (COCH) | United States | $0.101B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.098B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.086B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.073B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.072B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.059B | 0.00 |
| Hyperfine (HYPR) | United States | $0.059B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.056B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.056B | 113.33 |
| Vasomedical (VASO) | United States | $0.054B | 9.73 |
| Vicarious Surgical (RBOT) | United States | $0.050B | 0.00 |
| InspireMD (NSPR) | Israel | $0.046B | 0.00 |
| DarioHealth (DRIO) | United States | $0.043B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.042B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.042B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.039B | 0.00 |
| LENSAR (LNSR) | United States | $0.036B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.036B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Spectral AI (MDAI) | United States | $0.032B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.023B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.021B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.021B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.019B | 0.00 |
| PAVmed (PAVM) | United States | $0.017B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.017B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.015B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.005B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |